A Practical “Pretacs-Cytoblot” Platform Accelerates the Streamlined Development of PROTAC-based Protein Degraders

Zijian Rao,Kailin Li,Ju Hong,Danni Chen,Baoli Ding,Li Jiang,Xuxin Qi,Jiawen Hu,Bo Yang,Qiaojun He,Xiaowu Dong,Ji Cao,Cheng-Liang Zhu

DOI: https://doi.org/10.1016/j.ejmech.2023.115248

IF: 7.088

2023-01-01

European Journal of Medicinal Chemistry

Abstract:With the growing importance of PROTAC-mediated protein degradation in drug discovery, robust synthetic methodologies and rapid screening assays are urgently needed. By harnessing the improved alkene hydroazidation reaction, we developed a novel strategy to introduce azido groups into the linker-E3 ligand conjugates and effectively created a range of prepacked terminal azide-labeled “preTACs” as PROTAC toolkit building blocks. Moreover, we demonstrated that preTACs are ready to conjugate to ligands targeting a protein of interest to generate libraries of chimeric degraders, which are subsequently screened for effective protein degradation directly from cultured cells with a cytoblot assay. Our study exemplifies that this practical “preTACs-cytoblot” platform allows efficient PROTAC assembly and rapid activity assessments. It may help industrial and academic investigators to accelerate their streamlined development of PROTAC-based protein degraders.